Study of aleniglipron in people with liver problems
This study tests a medicine called aleniglipron in people with different levels of liver function. It aims to understand how the liver affects the medicine in the body, which could help doctors decide on the right dose for people with liver issues.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 85 years old.
- You have a body mass index (BMI) between 17 and 40.
- You are a non-smoker or smoke 10 or fewer cigarettes per day (or equivalent) and have kept the same smoking status for at least 3 months.
- You agree to use effective contraception if you or your partner could become pregnant.
- You have not used weight-loss medications (including GLP-1 receptor agonists) in the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the medicine PF-07328948 is processed by people with different levels of liver function. It includes both healthy people and those with stable liver disease (classified as mild, moderate, or severe). The goal is to see if the liver condition affects how the drug works in the body.
This research study tests how two experimental drugs (AZD9550 and AZD6234) work in people with different levels of liver function. The goal is to understand whether liver disease changes how the body processes these medications, which may help doctors safely treat patients with liver problems in the future.
This study tests how a new medicine, BI 3000202, is absorbed into the blood. It includes people with different levels of liver function (normal, mild, moderate, or severe) to see if liver problems affect how the medicine works.
This study tests how a new drug (AZD4144) is processed by the body in people with different levels of liver function. It aims to see if the drug is safe and how the liver affects its levels, which may help guide future dosing for patients with liver problems.
This study tests a drug called radiprodil in people with different levels of liver problems. It helps doctors understand how the liver processes the drug, which could make future treatments safer.
This trial tests a new medicine called eloralintide in people with healthy livers and in those with mild, moderate, or severe liver damage. It helps researchers learn how the liver affects the medicine in the body.
Hear when a new Hepatic Impairment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.